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The objective of this study was to relate the number of ventricular arrhythmias ( VA) to the normalization time of the ST
segment during thromboiysis for acute myocardial infarction. The 24 h Holter recordings, begun on start of intravenous
thrombolytic therapy, and the 12-lead electrocardiograms of 41 patients with a patent infarct-related artery according to
coronary angiography were analysed. The mean time from onset of chest pain to angiography was 30-5 ±31 h, ^24 h in
59%. The normalization time of the ST segment, assessed by the time of decrease of ST segment elevation from start of
Holter recording to normal or steady state was ^60 min in 13 patients (group l),60 to 180 min in 15 patients (group 2)
and > 180 min in 13 patients (group 3). The incidence ofVA was similar in all groups, except for ventricular tachycardias
(VT) > 15 beats (group 1:69%, group 2:13%, group 3:15%, P = 0002). The frequency of accelerated idioventricular
rhythms (AIVR), early AIVR (^6 h) and of VT was significantly higher in group 1 than in group 3 with a 8-, 30-and 6-
fold increase, respectively (back transformed mean). We conclude that the number of VAs is related to the normalization
time of the ST segment during reperfusion. This may suggest that faster reflow is more arrhythmogenic.
Introduction
Ventricular arrhythmias and ST segment changes are
non-invasive signs of reperfusion during thrombolytic
therapy for acute myocardial infarction1'-21. The frequency
of occurrence of ventricular arrhythmias and the time
course of ST segment normalization vary between
patients with successful reperfusion. The latter may
suggest differences in the speed of reperfusion. We have
investigated the relationship between ventricular arrhyth-
mias and the course of ST segment normalization, the
latter as a possible expression of the speed of reperfusion
of the infarct-related artery.
Methods
STUDY PATIENTS
Forty-eight consecutive patients hospitalized for trans-
mural acute myocardial infarction within 8 h of onset of
chest pain, who had no contra-indication to thrombolytic
therapy and who had given their informed consent were
included in the study. Intravenous thombolytic treatment
consisted of streptokinase(l-5 million units in 45 min) or
of recombinant tissue-type plasminogen activator (70 to
100 mg in 90 to 180 min after a bolus of 10 mg). Adminis-
tration of heparin was systematically begun at the end of
infusion of the thrombolytic agent. No beta-blocker or
calcium-channel antagonist was administered before or
together with thrombolytic treatment. After publication
of the results of the Second International Study of Infarct
Survival131, the last 14 patients received an intravenous
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bolus of 250 mg of aspirin on start of the infusion of
thrombolytic treatment. No preventive antiarrhythmic
treatment was given.
Twelve- or 15-lead electrocardiograms were recorded
on a simultaneous 3-lead Mingocard 4 electrocardio-
graphic recorder (Siemens-Elema) at the beginning of
thrombolytic treatment and at 0-25, 0-5, 0-75, 1,1-5, 2, 3,
6, 12, 24 and 48 h after start of the infusion. Continuous
electrocardiographic monitoring was performed on a
RCM 32 (ELA Medical) monitor.
Blood samples for the determination of plasma levels of
creatine kinase were obtained on start of the infusion of
thrombolytic treatment and 1, 2, 3, 4, 8, 12, 24 and 48 h
after the beginning of infusion.
Twenty-four-hour two-channel Holter recording was
performed using an ELA 2448 analogic Holter recorder
with amplitude modulation and a recording speed of
I m m . s " ' (ELA Medical). Holter recording began as
soon as possible after admission to the hospital and the
tapes were analysed on a digital system (Laser Holter,
Marquette Electronics). Each morphological pattern
(normal and ventricular complexes) was validated beat
after beat. Rhythmic events with the validated ventricular
complexes were then defined as isolated ventricular
premature complexes, couplets or runs of > three beats.
Each ventricular run was individually inspected in all
patients and then studied for its length and rate. The rate
of a run was classified according to the two shortest con-
secutive RR intervals. All rhythmic events were studied
on an hourly basis. The ST segment algorithm used
incremental averaging. Each normal QRS complex was
compared with a median template.
Coronary angiography was performed as part of the pro-
tocol in all patients. The infarct-related artery grade flow
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was assessed by two blinded independent observers accord-
ing to the criteria defined in the Thrombolysis in Myocar-
dial Infarction trial141. Only the subgroup of patients in
whom the infarct-related artery was found to be patent
(grade 2 or 3) were included in the analysis. Left ventricular
ejection fraction was calculated from the right anterior
oblique angiographic view according to Dodge's method.
Coronary artery diameters were evaluated with a caliper.
The mean of the pre- and post-stenosis diameters was used
to evaluate residual stenosis of the infarct-related artery.
The following parameters were considered: the ST
segment changes were evaluated from Holter recordings
(two-lead printings with an amplitude of 1 mV . cm"1 and
a recording speed of 25 mm . s"' and computerized analy-
sis of the ST segment). When ST segment changes were
not clear from Holter recordings, they were evaluated
from 12-lead electrocardiograms, in the lead with the
most pronounced ST segment elevation. The normaliz-
ation time of the ST segment was defined by the time of
decrease from ST segment elevation on start of Holter
recording to normal or to steady state'51. The amplitude of
ST segment decrease was considered significant if > 50%
from initial value'21.
The ventricular arrhythmias studied were divided into
isolated and total ventricular premature complexes (iso-
lated ventricular premature complexes plus ventricular
premature complexes of all runs), accelerated idioven-
tricular rhythms (run of > three consecutive ventricular
premature complexes at a rate < 125 beats. min~'), and
ventricular tachycardias (run of > three monomorphic
or polymorphic consecutive ventricular premature com-
plexes at a rate > 125 beats. min"') which were specified
as prolonged ventricular tachycardia (> 15 beats) or rapid
ventricular tachycardia (>200 beats . min"'), and ven-
tricular fibrillation. We have previously reported that
accelerated idioventricular rhythms may occur in patients
with an occluded artery, but that their onset was delayed
beyond the fifth hour following the start of thrombolytic
therapy. This is in contrast to patients with a patent artery
in which this had already been observed in the first hour'61.
Therefore, we have specifically studied early accelerated
idioventricular rhythms i.e. occurring within the first 6 h
of recording.
STATISTICAL ANALYSIS
Quantitative data were expressed as mean + SEM.
One-way analysis of variance was used for continuous
variables. Categorical variables were compared between
groups by the chi-square test. To meet the distri-
butional assumptions for analysis of variance, arrhythmia
frequencies were transformed by log 10 ( s + 1). Descrip-
tive statistics include mean and standard error of fre-
quencies in addition to back transformed mean of the log
transformed data.
Results
ARRHYTHMIAS IN PATIENTS WITH A PATENT INFARCT-
RELATED ARTERY
Forty-one patients with a patent artery (rate of
patency: 85%) were evaluated: 83% male, mean age:
Table I Incidence of ventricular arrhythmias in patients with a patent
artery (n = 4l)
Premature ventricular complexes
Accelerated idioventricular rhythm
Accelerated idioventricular rhythm $ 6 h
Ventricular tachycardia
Prolonged ventricular tachycardia
Rapid ventricular tachycardia
Ventricular fibrillation
41 (100%)
37 (90%)
29 (71%)
32 (78%)
13 (32%)
10 (24%)
1 (2%)
55+1-5 years (range 33 to 72), 37% with anterior infarc-
tion, 12% with prior myocardial infarction. The first 10
patients (24%) were treated with streptokinase and the
following 31 (76%) were given recombinant tissue-type
plasminogen activator. Mean delay from chest pain to
thrombolysis was 3-3±O-2h (range 0-75 to 7-25). The
mean time from onset of chest pain to the beginning of
Holter recording was 3-2 + 0-2 h (range 0-67 to 7). Holter
monitoring began before thrombolysis in 83% of the
patients. The mean duration of recording was 23-8 + 0-4 h
(range 11-6 to 25-5). Coronary angiography was per-
formed with a mean delay from the start of chest pain of
30-5 + 3 1 h (range 5 to 75); in 24 cases (59%), this was
within the first 24 h.
All patients had ventricular arrhythmias (Table 1).
Tolerance was good even in the presence of a prolonged
or a rapid ventricular arrhythmia. Cardioversion was
required only once for ventricular fibrillation starting
with an R on T phenomenon occurring before ST segment
decrease. No arrhythmic death occurred during the study.
ARRHYTHMIAS AND ST SEGMENT
Three groups of patients were defined according to the
normalization time of the ST segment: < 60 min (group 1;
n = 13), 60 to 180 min (group 2; n = 15), > 180 min (group
3; n = 13). No significant statistical differences were found
between the three groups with regard to baseline clinical
characteristics (Table 2).
The prevalence (expressed as percentage of patients
with >one episode) of the ventricular arrhythmias that
we have considered was not statistically different in the
three groups, except for prolonged ventricular tachycar-
dia, the incidence of which was higher in group 1 than in
groups 2 and 3: 69, 13 and 15%, respectively (/> = 0-002).
The average frequency of the ventricular arrhythmias in
the three groups is listed in Table 3. All arrhythmias were
more frequent in group 1 than in group 2 and than in
group 3. The frequency of accelerated idioventricular
rhythms, early accelerated idioventricular rhythms and
ventricular tachycardias was significantly higher in group
1 than in group 3, with a 8-, 30- and 6-fold increase,
respectively when back transformed means were con-
sidered. The increased frequency of ventricular tachycar-
dias included a higher number of prolonged ventricular
tachycardias, as well as of short lasting ventricular tachy-
cardias. The time course of the hourly total frequency
of accelerated idioventricular rhythms and ventricular
tachycardias throughout the 24 h of recording in groups
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Table 2 Clinical characteristics of patients according to the normalization time of the ST segment
ST segment normalization time Group I (n= 13)$ 60 min
Group 2 (n= 15)
60-180min
Group 3 (n = 13)
>180min
Sex (% males)
Age (years)
Infarct location (% anterior)
Thrombolysis (% streptokinase)
Aspirin (% patients on aspirin)
Delay from pain to thrombolysis (h)
Delay from pain to peak creatine kinase (h)
Delay from thrombolysis to peak creatine kinase (h)
Peak creatine kinase (IU . 1 ')
Delay from pain to angiography (h)
Delay from pain to Holter (h)
Holter duration (h)
Ejection fraction (%)
Residual stenosis (%)
11 (85%)
55 + 3
4(31%)
5 (38%)
3(23%)
3-0±0-5
15-2+1 6
12-2+1 7
2750 + 526
32-4 + 6-3
30±0-5
23 5 ±0-9
55 + 4
70 + 4
11 (73%)
54 + 3
4 (27%)
3 (20%)
7 (47%)
3-3±O-3
16-7 + 1 4
13-4+1-2
2277 + 401
29-4 + 4-9
3-1+0-3
24-0 + 0-9
59 + 3
68 + 6
12(92%)
58 + 2
7 (54%)
2(15%)
4(44%)
3-5±O-3
15-5+1-7
121 + 1-7
2262 + 419
29-7 + 5-5
3-4 + 0-4
23-9 + 0-4
54 + 5
63 + 7
All results NS
Table 3 Frequency of ventricular arrhythmias according to the normalization time of the ST segment
ST segment normalization time Group 1 (n=13)
^60 min
Group 2 (n= 15)
60-180min
Group 3 (n= 13)
>180min
Single premature ventricular complexes
Total premature ventricular complexes
Couplets
Accelerated idioventricular rhythm
Accelerated idioventricular rhythm ;S6h
Ventricular tachycardia
Prolonged ventricular tachycardia
Short lasting ventricular tachycardia
Rapid ventricular tachycardia
1428+475
5925+1786
168 + 57
258 + 84
174 + 52
74 + 45
12 + 7
61+38
3±2
(660)
(1819)
(49)
(46)
(30)
(12)
(3)
(11)
(1)
1091+351
1926 + 718
65 + 27
66 + 31
22+13
9±6
1-3+1-2
7±5
0-8 ±0-7
(574)
(911)
(29)
(19)
(4)
(3)
(0-3)
(3)
(0-2)
404+104
596+146
25 + 7
22+14
5 + 3
4±1
0-2 + 0-1
4 + 1
0-5 + 0-3
(281)
(406)
(14)
(6)
(1)
(2)
(01)
(2)
(0-3)
NS
<005**
NS
005**
0005*
0-02*
0006*
0-03"
NS
Mean + SEM (back transformed mean), * 1 versus 2 and 1 versus 3, **1 versus 3.
P values are for log tranformed data.
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Figure 1 Hourly average frequency of accelerated idioventricular rhythm according to the
normalization time of the ST segment. • = group 1; O = group 2; • = group 3.
1, 2 and 3 are shown in Figs 1 and 2, respectively. These
figures show a very high frequency of accelerated idioven-
tricular rhythms and ventricular tachycardias in group 1
during the early hours after start of Holter recordings.
Moreover, those arrhythmias occur early, with a peak of
ventricular tachycardias during the second hour of
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Figure 2 Hourly average frequency of ventricular tachycardia according to the normalization
time oftheST segment. • =group 1; O=group2; • =group3.
recording and a slightly delayed peak of accelerated
idioventricular rhythms during the fourth hour. The fre-
quency of both arrhythmias is very low beyond the tenth
hour of recording.
Discussion
Studies with Holter recordings and continuous electro-
cardiographic monitoring have shown that ventricular
arrhythmias are frequent and well tolerated during
thrombolysis'6"81. Coronary artery patency is associated
with an increase in incidence'8"101 and/or frequency'6"' of
ventricular tachycardias and accelerated idioventricular
rhythms. Several authors have tried to identify factors
which may influence this arrhythmogenicity of reper-
fusion. Usual clinical parameters, such as age, infarct
location, gender, the thrombolytic agent used (strepto-
kinase or recombinant tissue-type plasminogen activator),
the interval from onset of chest pain to thrombolysis and
reperfusion were not found to influence the prevalence and
frequency of ventricular arrhythmias'6'8'9'. In addition, no
correlation was demonstrated between the number of runs
of accelerated idioventricular rhythm and peak creatine
kinase activity, serum potassium and creatinine, sinus rate
and number of diseased vessels'69"'; only Cercek et a/.'8'
found a significant positive correlation between the
maximal initial ST segment elevation ( < o r > 2 mm) and
frequency of accelerated idioventricular rhythm.
Currently, routine thrombolysis is based on intra-
venous rather than intracoronary administration of
fibrinolytic agents and coronary angiography is not per-
formed in the acute phase in most of the cases. It may still
be required, particularly when thrombolysis has failed
to achieve patency. The need to identify reperfusion has
led to the search for non-invasive criteria, such as chest
pain relief1'-8', ST segment changes and/or ventricular
arrhythmias'1-2-5-6-8-9-"12' or creatine kinase or myoglobin
kinetics'13"15'. Angiographic studies have demonstrated
a fall in ST segment concomitant with the restoration
of antegrade flow'71 and a chronological relationship
between the latter and onset of ventricular arrhythmias'71.
The best criterion (in terms of sensitivity and specificity
for the diagnosis of reperfusion) of ST segment change
has not yet been clearly established'2-5"'.
Our hypothesis is that the normalization time of the ST
segment is related to the speed of reperfusion. If this is
correct, then our observation of a higher frequency of
ventricular arrhythmias in the group where the normal-
ization time of the ST segment is short in comparison to
groups where it lasts longer suggests that fast reperfusion
is more arrhythmogenic than slow reperfusion. This is
consistent with the low frequency of ventricular arrhyth-
mias that we had previously observed in non-reperfused
patients'6'. It is interesting to note that the two arrhyth-
mias the incidence or frequency of which is highly signifi-
cantly linked to the normalization time of the ST segment
are prolonged ventricular tachycardias and early acceler-
ated idioventricular rhythms. All ventricular arrhythmias
considered, those two arrhythmias were the best non-
invasive criteria for coronary patency in our previous
work'6'.
In man, the potential deleterious effect of rapid reper-
fusion has been suggested by some authors. Particularly, a
residual stenosis of 80% or less was found to be a predis-
posing factor for the occurrence of ventricular fibrillation,
ventricular tachycardia and accelerated idioventricular
rhythm at reperfusion by Maras et a/."61 in a study of
intracoronary thrombolysis with acute documentation of
coronary patency. Because of the lower risk of ventricular
fibrillation observed in dogs with a flow-limiting partial
stenosis of the artery undergoing transient occlusion than
in dogs with normal coronary arteries'17', it was assumed
that the rate of reflow was higher when the residual sten-
osis was less severe and that it may play a role in the
arrhythmogenicity of reperfusion'16'. We did not find
any difference in residual stenosis between the three
groups. This may suggest that the speed of reperfusion is
dependent on other factors than residual stenosis.
In animal models, a short duration of ischaemia or a
rapid speed of reperfusion have been demonstrated to
precipitate the onset of reperfusion arrhythmias'17"19' but
the respective role of the status of the arrhythmogenic
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substrate (degree of ischaemia) or of the quality of the
trigger (the reperfusate composition)'18191 in the arrhyth-
mogenicity of reperfusion may be different depending on
the rate or on the delay of reperfusion. Sudden reflow
leads to abrupt washout of toxic metabolites or reoxy-
genation; this contributes to tissue heterogeneity and
rapid electrical instability leading to arrhythmias'18191.
Several metabolic changes due to ischaemia and/or
reperfusion, such as calcium overload, production of free
radicals, high fatty acid levels, impaired potassium and
magnesium concentrations have been thought to play a
role in the arrhythmogenicity of reperfusion1181. It has
been reported that the incidence of reperfusion arrhyth-
mias is decreased when the speed of reperfusion is
reduced, possibly because of slower and more uniform
washout of toxic metabolites'18'. These biochemical fac-
tors might accelerate the cellular damage due to ischaemia
and may thus be responsible for 'reperfusion injury''201. A
recent study has shown that staged reperfusion attenuates
myocardial stunning and that this beneficial effect is
primarily attributable to transient acidosis during early
reperfusion. Calcium overload as well as activation of
leucocytes and free-radical generation, which can be
attenuated by acidosis, have been reported to cause
myocardial stunning'2'1. We may assume that the higher
incidence of arrhythmias observed when reperfusion is
suspected to be more abrupt is indicative of a more severe
myocardial damage. We did not find any difference in
acute ejection fraction between the three groups, but
ejection fraction was not assessed again on a second
occassion such as 1 month after the acute phase; this could
have provided an insight on myocardial recovery. A pro-
spective study is underway to evaluate this interesting
issue.
Our study is limited by the small size of the population
and the lack of a more accurate method for the evaluation
of the speed of reperfusion. Furthermore, the relation-
ship between the frequency of occurrence of acute
arrhythmias and prognostic factors remains to be estab-
lished. Attempts to modify the reperfusate composition,
such as administration of free-radical scavengers or
angiotensin converting enzyme inhibitors have succeeded
in reducing the incidence of reperfusion arrhythmias in
animals'18'221. If arrhythmias may be considered as a
marker for reperfusion injury, their analysis may be
important during studies aimed to improve the quality of
reperfusion in man'23'.
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